Surfacide, the industry leader in UV-C disinfection technology, announced that it is expanding the use of Surfacide's best-in-class Helios low-level UV-C Disinfection System across...
Cure Rare Disease, a clinical-stage nonprofit biotechnology company, has been awarded an advocacy collaboration grant from the Muscular Dystrophy Association (MDA) to support research on novel...
Fresenius Kabi announced the immediate availability in the U.S. of Stimufend, the company’s biosimilar to Neulasta, for use in patients at risk for febrile...
Carevive Systems, Inc. a leading innovator in cancer care management software with a deep real-world evidence patient dataset, announced that it will launch the...
